Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Target Therapeutics buys Inverventional Therapeutics:

This article was originally published in Clinica

Executive Summary

Target Therapeutics has completed the acquisition of fellow neuroradiology company Interventional Therapeutics through a stock swap. The two companies intend to integrate their operations and will offer a range of minimally invasive treatment options for vascular diseases of the brain. Target's product line includes microcatheters, guidewires and microcoils, while Interventional Therapeutics concentrates on vascular occlusion devices used in neurovascular embolisation, such as detachable silicone balloons.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts